Real-world data on first relapse of acute lymphoblastic leukemia in patients >55 years.
- Resource Type
- Article
- Authors
- Lennmyr, Emma Bergfelt; Kozlowski, Piotr; Ahlberg, Lucia; Bernell, Per; Hulegårdh, Erik; Izarra, Antonio Santamaria; Karlsson, Karin; Tomaszewska-Toporska, Beata; Åström, Maria; Hallböök, Helene
- Source
- Leukemia & Lymphoma. Oct2018, Vol. 59 Issue 10, p2470-2473. 4p.
- Subject
- *LYMPHOBLASTIC leukemia
*RANDOMIZED controlled trials
*HEMATOPOIETIC stem cells
*PROTEIN-tyrosine kinases
*CANCER chemotherapy
- Language
- ISSN
- 1042-8194
The article offers information on a study regarding treatment and survival after first acute lymphoblastic leukemia (ALL) relapse in an older population and controls for these patients outside of randomized controlled trials. It mentions information on use of allogeneic hematopoietic stem cell transplantation (hSCT) in second remission (CR2). It presents efficiency of tyrosine kinase inhibitors (TKI) and blinatumomab. It also mentions information on impact of TKI and chemotherapy.